<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719011</article-id><article-id pub-id-type="pmc">6852461</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0322</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The Status and Research Progress on Vitamin D Deficiency and Atrial
Fibrillation</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7437-6436</contrib-id><name><surname>Bie</surname><given-names>Lizhan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><aff id="aff1">
<label>1</label>Department of Cardiology, the Third People&#x02019;s Hospital of
Yancheng, Yancheng, China.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: <bold>Lizhan Bie</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-7437-6436">https://orcid.org/0000-0002-7437-6436</ext-link>, Rui-Jin Hospital,
Shanghai Jiao-Tong University School of Medicine, Shanghai, China, 197 Rui Jin
2nd Road, Shanghai, China. E-mail: <email>11430999@qq.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>605</fpage><lpage>609</lpage><history><date date-type="received"><day>18</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Atrial fibrillation is a common type of arrhythmia and is an important cause of
stroke and heart failure. vitamin D is an emerging risk factor of AF, and is
implicated in the pathophysiology of atrial fibrillation. It has been
established that this vitamin is extensively involved in the regulation of both
the renin angiotensin aldosterone system and the immune system. Epidemiological
studies have not yet reached a consensus on the possible association between
vitamin D deficiency and atrial fibrillation. Better research designs and
methods can further clarify the relationship between the two.</p></abstract><kwd-group><kwd>Atrial Fibrillation</kwd><kwd>Vitamin D Deficiency</kwd><kwd>Pathophysiology</kwd><kwd>Epidemiology</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Atrial fibrillation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">FGF-23</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Fibroblast growth factor
23</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">IL</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Interleukin</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Not available</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">POAF</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Postoperative atrial
fibrillation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PTH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Parathyroid hormone</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RAAS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Renin-angiotensin-aldosterone system</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Tumor necrosis factor
alpha</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">VDBP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Vitamin D-binding
protein</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">VDR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Vitamin D receptor</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Atrial fibrillation (AF) is the most common type of arrhythmia. It is not a fatal
arrhythmia itself, but it can impair the quality of life and can easily lead to
stroke and increase the risk of cardiac death. AF epidemiological studies have
concluded that the prevalence of AF is underestimated, the most important reason is
the missed diagnosis of paroxysmal AF and the low enthusiasm for patients with
asymptomatic AF. As the age structure of the population changes, the proportion of
elderly increases, and other risk factors such as hypertension, diabetes, and
cardiovascular disease increase, it is foreseeable that the future prevalence of AF
will continue to increase.</p><p>At present, the pathogenesis of AF is not clear. Although antiarrhythmic drugs are
widely used in clinical treatment, the effects of these drugs are not satisfactory
due to frequent recurrence of AF and significant proarrhythmic effects<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Radiofrequency ablation and other
procedures for patients with AF are not ideal for long-term benefit; therefore,
upstream treatment of AF, the prevention of AF episodes is more important. Exploring
targets that are new and easy to detect and control has become a new goal for the
treatment of AF. Since 1990, Kessel<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup> reported a case of taking vitamin D to cure chronic AF, and the
relationship between vitamin D deficiency and AF has gradually become a research
hotspot.</p></sec><sec><title>POSSIBLE MECHANISM</title><p>In the past studies, vitamin D research had been concentrated on bone metabolism. In
recent years, studies have found out that vitamin D deficiency is involved in the
pathogenesis of hypertension, heart failure, coronary heart disease, and
obesity<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. These factors
are also common risk factors for AF. The biological effects of vitamin D are mainly
derived from its binding to the nuclear steroid hormone vitamin D receptor (VDR),
which exists in almost all tissues, including cardiac myocytes, and is involved in
the structural changes of cardiac cells<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>It is well known that AF is closely associated with an inflammatory milieu. Vitamin D
can increase the production of interleukin (IL)-10 and reduce the production of
IL-6, IL-12, interferon-&#x003b3;, and tumor necrosis factor alpha (TNF-&#x003b1;),
thereby generating a cytokine spectrum that is conducive to reduce
inflammation<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> and the
reduction of vitamin D and vitamin D-binding protein (VDBP) as part of the acute
inflammatory system response. However, studies have suggested that vitamin D
deficiency may be a consequence, not a cause of inflammation<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. And vitamin D supplementation may
delay the inflammatory response caused by decreased VDR function<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Vitamin D is a negative endocrine
regulator of the renin-angiotensin-aldosterone system (RAAS)<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>, and low plasma 25-hydroxyvitamin
D3 levels may result in upregulation of the RAAS<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>, while inhibition of the RAAS can prevent the onset of
AF<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Vitamin D
deficiency may impair the prevention of AF by inhibiting RAAS<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>The study found out that hemodialysis patients may inhibit the expression of vitamin
D through fibroblast growth factor 23 (FGF-23) and promote the formation of
AF<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Mathew
demonstrated a consistent association between high circulating FGF-23 concentrations
and an increased risk of developing AF<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. High FGF-23 levels inhibit 1-alpha hydroxylase activity
and reduce vitamin D3 production<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. It is confirmed from the side that vitamin D deficiency is
associated with AF.</p><p>Hanafy et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> found out that
vitamin D can extend the action potential duration without increasing the
contraction pressure of the left atrium. It can also reduce AF attacks and even
terminate AF. And it did not prolong QT interval and did not increase the chance of
ventricular arrhythmia. Canpolat et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> found out that the electromechanical delay in AF patients
with vitamin D deficiency was significantly increased, and the electromechanical
delay of atrium after vitamin D supplementation was reduced. The incidence of AF was
increased by the electromechanical delay of atrium. These studies suggest that
vitamin D supplementation may be a potential treatment for AF.</p></sec><sec><title>EPIDEMIOLOGICAL RESEARCH</title><p>The pathogenesis of AF itself is not clear, so it is more meaningful to explore the
relationship between AF and vitamin D from an epidemiological perspective. <xref rid="t1" ref-type="table">Table 1</xref> summarizes the recent studies on the
relationship between vitamin D deficiency and AF.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Epidemiological study of atrial fibrillation (AF) and vitamin D
deficiency.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="60%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Study (year)</th><th align="center" rowspan="2" colspan="1">Subject</th><th align="center" rowspan="2" colspan="1">Total patients</th><th align="center" colspan="2" rowspan="1">Result</th></tr><tr><th align="center" rowspan="1" colspan="1">Prevalence</th><th align="center" rowspan="1" colspan="1">Incidence</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Rienstra et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Two American community cohorts without prevalent
AF</td><td align="center" rowspan="1" colspan="1">2930</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Vacek et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup></td><td align="center" rowspan="1" colspan="1">A cohort of patients</td><td align="center" rowspan="1" colspan="1">10899</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Vitezova et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup></td><td align="center" rowspan="1" colspan="1">A community-based cohort of middle-aged and elderly
participants</td><td align="center" rowspan="1" colspan="1">3395</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Alonso et al.<sup><xref rid="r19" ref-type="bibr">19</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Four communities in the United States of America</td><td align="center" rowspan="1" colspan="1">12303</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Shadvar et al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients undergoing CABG</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Emren et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients undergoing CABG</td><td align="center" rowspan="1" colspan="1">283</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Cerit et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients undergoing CABG</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">No</td></tr><tr><td align="left" rowspan="1" colspan="1">Gode et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients undergoing CABG</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000d6;zsin et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients undergoing CABG</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Belen et al.<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients with chronic heart failure</td><td align="center" rowspan="1" colspan="1">180</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Ozcan et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Hypertensive patients</td><td align="center" rowspan="1" colspan="1">227</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td align="left" rowspan="1" colspan="1">Canpolat et al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Lone paroxysmal AF</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Demir et al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Successive cardiology outpatient</td><td align="center" rowspan="1" colspan="1">298</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Qayyum et al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Patients in the department of cardiology with AF</td><td align="center" rowspan="1" colspan="1">258</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Non-valvular persistent AF</td><td align="center" rowspan="1" colspan="1">322</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">May et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup></td><td align="center" rowspan="1" colspan="1">A general cardiovascular population without
depression <break/>(&#x02265; 50 years old)</td><td align="center" rowspan="1" colspan="1">7358</td><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">NA</td></tr><tr><td align="left" rowspan="1" colspan="1">Fusaro et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup></td><td align="center" rowspan="1" colspan="1">Hemodialysis patients</td><td align="center" rowspan="1" colspan="1">314</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>CABG=coronary artery bypass grafting; NA=not available</p></fn></table-wrap-foot></table-wrap><p>First, in a large sample of community studies, the relationship between AF and
vitamin D deficiency appears confusing. Rienstra et al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>, Vitezova et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>, and Alonso et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> found out that there were no clear relations, but
Vacek et al.<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup> thought they were
related. The biggest difference between the two types of studies was the age of the
study population. The average age of the study population in Rienstra was 66 years,
the age of those in Vitezova was 71 years, and the study population in Vacek was
relatively young, with an average age of 55 years. Among the risk factors for the
incidence of AF, age is an independent and relatively important one. With increasing
age, the risk factors for AF are high. Alonso's study was interesting, he found out
that vitamin D deficiency was not associated with AF risk in different genders and
ethnic groups, and as with other prospective studies, meta-analysis did not support
the correlation between these two. However, he also pointed out that there was still
a correlation between AF and vitamin D deficiency in a relatively young population
(&#x0003c; 58). The lower the concentration of vitamin D, the more likely it was to
contribute to the formation of AF, while in the old population, the effect was not
obvious.</p><p>Secondly, in the classification study with relatively small sample size, the
relationship between AF and vitamin D deficiency in different types of patients is
also widely debated.</p><p>The relationship between vitamin D deficiency and postoperative AF (POAF) in patients
is also unclear. Cerit found out that although there was a significant negative
correlation between vitamin D and left atrial diameter, it was surprising that
regression analysis showed that vitamin D deficiency was not an independent
predictor of POAF<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. In
subsequent studies, he found out that vitamin D supplementation can prevent the
occurrence of POAF when vitamin D is extremely deficient<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The other four studies supported that vitamin D
deficiency directly led to an increased incidence of POAF<sup>[<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r26" ref-type="bibr">26</xref>]</sup>. The
patients enrolled in the study by Gode et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup> and &#x000d6;zsin et al.<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup> were young, and all studies supported a left
atrial diameter as an independent risk factor for POAF. Overall evidence of vitamin
D deficiency seems to support the onset of POAF.</p><p>In studies about the type of AF and the degree of vitamin D deficiency, Qayyum et
al.<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup> found out that the
degree of vitamin D deficiency was not associated with the type of AF episode and it
was not associated with a thrombotic event. May et al.<sup>[<xref rid="r28" ref-type="bibr">28</xref>]</sup> conducted a stratified analysis of the
concentration of vitamin D in cardiovascular patients over 50 years of age, and
found out that the prevalence of AF was basically the same under different levels of
vitamin D deficiency. However, the subjects of this type of study were also older
and had more chronic diseases than the ones of other studies.</p><p>The results of studies on non-valvular AF, especially lone AF and vitamin D
deficiency, are encouraging. Canpolat et.al.<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup> found out that vitamin D deficiency and progression of AF
were associated in a controlled study of patients with lone paroxysmal AF and
healthy people, and that atrial fibrosis was demonstrated in patients with vitamin D
deficiency by magnetic resonance imaging (MRI); more significantly, atrial fibrosis
is an important marker of AF, and multivariable Cox regression analysis found out
that vitamin D lacks were an independent risk factor for atrial fibrosis. Demir et
al.<sup>[<xref rid="r30" ref-type="bibr">30</xref>]</sup> found out that the
level of vitamin D in patients with non-valvular AF was significantly lower than in
patients without AF and with valvular AF, and that parathyroid hormone (PTH) levels
were significantly higher in patients with non-valvular AF than in those without AF.
This result suggested that hyperparathyroidism secondary to vitamin D deficiency may
play a role in AF. The clinical effect of vitamin D deficiency was thought to be the
result of reduced calcium absorption, which, in turn, increased PTH levels, but
vitamin D levels in patients with valvular AF were similar to those in healthy
controls. Chen et al.<sup>[<xref rid="r31" ref-type="bibr">31</xref>]</sup>
rigorously screened 162 patients with chronic AF (excluding many chronic diseases:
diabetes, hypertension, coronary heart disease, etc.) and 160 healthy individuals
without AF, and found low vitamin D levels associated with the prevalence of AF.
Ozcan et al.<sup>[<xref rid="r32" ref-type="bibr">32</xref>]</sup> also rigorously
screened subjects and found out that vitamin D deficiency was associated with
new-onset AF in hypertension. Also, in patients with chronic heart failure, low
vitamin D concentrations were an independent risk factor for non-valvular AF, and
the study also ruled out many chronic diseases<sup>[<xref rid="r33" ref-type="bibr">33</xref>]</sup>.</p><p>Through the meta-analysis of several studies, it was found out that vitamin D
deficiency was associated with the occurrence of AF. In patients with chronic AF,
vitamin D deficiency was associated with the development of AF, and the risk of AF
increased to a certain extent<sup>[<xref rid="r34" ref-type="bibr">34</xref>]</sup>;
while focusing on new-onset AF, there was no significant association between vitamin
D status and risk of AF<sup>[<xref rid="r34" ref-type="bibr">34</xref>,<xref rid="r35" ref-type="bibr">35</xref>]</sup>; however, due to the
heterogeneity of the studies included in this study, the results were not
convincing.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The relationship between vitamin D deficiency and AF still requires more basic
research support in the study of mechanisms (<xref ref-type="fig" rid="f1">Figure
1</xref>), and the results of epidemiological investigations are more convenient
for guiding clinical work. Through several research findings, it can be inferred
that vitamin D is in the process of AF, and the weight is not large compared with
other risk factors, such as advanced age, hypertension, and coronary heart disease.
The connection between the two is not suitable for large-scale community survey
research and is not suitable for research in the elderly and people with more basic
diseases. The exploration of the relationship between the two requires a more
accurate classification of research. There may be unexpected surprises in the study
of designated populations, such as patients with isolated AF and patients with
low-grade non-valvular AF. Studies on whether vitamin D supplements prevent AF also
need to be precisely classified.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Mechanism of vitamin D deficiency leading to atrial fibrillation.</p></caption><graphic xlink:href="rbccv-34-05-0605-g01"/></fig>
</p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">LB</td><td align="left" valign="top" rowspan="1" colspan="1">Agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published.</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Department of Cardiology, the Third People&#x02019;s
Hospital of Yancheng, Yancheng, China.</p></fn><fn fn-type="other"><p><bold>Compliance with Ethics Guidelines</bold></p><p>This manuscript is a review article and does not involve a research protocol,
which would require approval by the relevant institutional review board or
ethics committee.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saksena</surname><given-names>S</given-names></name><name><surname>Slee</surname><given-names>A</given-names></name><name><surname>Waldo</surname><given-names>AL</given-names></name><name><surname>Freemantle</surname><given-names>N</given-names></name><name><surname>Reynolds</surname><given-names>M</given-names></name><name><surname>Rosenberg</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation
Follow-Up Investigation of Rhythm Management). An assessment of individual
antiarrhythmic drug therapies compared with rate control with propensity
score-matched analyses</article-title><source>J Am Coll Cardiol</source><year>2011</year><volume>58</volume><issue>19</issue><fpage>1975</fpage><lpage>1985</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2011.07.036</pub-id><pub-id pub-id-type="pmid">22032709</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessel</surname><given-names>L</given-names></name></person-group><article-title>Sick sinus syndrome cured by ... vitamin D?</article-title><source>Geriatrics</source><comment>[Internet]</comment><year>1990</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>45</volume><issue>8</issue><fpage>83</fpage><lpage>85</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/2379840">https://www.ncbi.nlm.nih.gov/pubmed/2379840</ext-link></comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Pilz</surname><given-names>S</given-names></name><name><surname>M&#x000e4;rz</surname><given-names>W</given-names></name><name><surname>Micha&#x000eb;lsson</surname><given-names>K</given-names></name><etal/></person-group><article-title>Circulating 25-hydroxy-vitamin D and risk of cardiovascular
disease: a meta-analysis of prospective studies</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2012</year><volume>5</volume><issue>6</issue><fpage>819</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.112.967604</pub-id><pub-id pub-id-type="pmid">23149428</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Law</surname><given-names>CS</given-names></name><name><surname>Grigsby</surname><given-names>CL</given-names></name><name><surname>Olsen</surname><given-names>K</given-names></name><name><surname>Hong</surname><given-names>TT</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cardiomyocyte-specific deletion of the vitamin D receptor gene
results in cardiac hypertrophy</article-title><source>Circulation</source><year>2011</year><volume>124</volume><issue>17</issue><fpage>1838</fpage><lpage>1847</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.032680</pub-id><pub-id pub-id-type="pmid">21947295</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleithoff</surname><given-names>SS</given-names></name><name><surname>Zittermann</surname><given-names>A</given-names></name><name><surname>Tenderich</surname><given-names>G</given-names></name><name><surname>Berthold</surname><given-names>HK</given-names></name><name><surname>Stehle</surname><given-names>P</given-names></name><name><surname>Koerfer</surname><given-names>R</given-names></name></person-group><article-title>Vitamin D supplementation improves cytokine profiles in patients
with congestive heart failure: a double-blind, randomized,
placebo-controlled trial</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><issue>4</issue><fpage>754</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1093/ajcn/83.4.754</pub-id><pub-id pub-id-type="pmid">16600924</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldron</surname><given-names>JL</given-names></name><name><surname>Ashby</surname><given-names>HL</given-names></name><name><surname>Cornes</surname><given-names>MP</given-names></name><name><surname>Bechervaise</surname><given-names>J</given-names></name><name><surname>Razavi</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>OL</given-names></name><etal/></person-group><article-title>Vitamin D: a negative acute phase reactant</article-title><source>J Clin Pathol</source><year>2013</year><volume>66</volume><issue>7</issue><fpage>620</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1136/jclinpath-2012-201301</pub-id><pub-id pub-id-type="pmid">23454726</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>PJ</given-names></name><name><surname>Proal</surname><given-names>AD</given-names></name><name><surname>Marshall</surname><given-names>TG</given-names></name></person-group><article-title>Vitamin D: the alternative hypothesis</article-title><source>Autoimmun Rev</source><year>2009</year><volume>8</volume><issue>8</issue><fpage>639</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.autrev.2009.02.011</pub-id><pub-id pub-id-type="pmid">19393200</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Kong</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>ZF</given-names></name><name><surname>Liu</surname><given-names>SQ</given-names></name><name><surname>Cao</surname><given-names>LP</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of
the renin-angiotensin system</article-title><source>J Clin Invest</source><year>2002</year><volume>110</volume><issue>2</issue><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1172/JCI15219</pub-id><pub-id pub-id-type="pmid">12122115</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname><given-names>JP</given-names></name><name><surname>Williams</surname><given-names>JS</given-names></name><name><surname>Fisher</surname><given-names>ND</given-names></name></person-group><article-title>Plasma 25-hydroxyvitamin D and regulation of the
renin-angiotensin system in humans</article-title><source>Hypertension</source><year>2010</year><volume>55</volume><issue>5</issue><fpage>1283</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.109.148619</pub-id><pub-id pub-id-type="pmid">20351344</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>MP</given-names></name><name><surname>Hua</surname><given-names>TA</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Wachtell</surname><given-names>K</given-names></name><name><surname>Kjeldsen</surname><given-names>SE</given-names></name><name><surname>Schmieder</surname><given-names>RE</given-names></name></person-group><article-title>Prevention of atrial fibrillation by Renin-Angiotensin system
inhibition a meta-analysis</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>55</volume><issue>21</issue><fpage>2299</fpage><lpage>2307</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2010.01.043</pub-id><pub-id pub-id-type="pmid">20488299</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turin</surname><given-names>A</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Doukas</surname><given-names>D</given-names></name><name><surname>Joyce</surname><given-names>C</given-names></name><name><surname>Lopez</surname><given-names>JJ</given-names></name><name><surname>Mathew</surname><given-names>V</given-names></name><etal/></person-group><article-title>Interactions among vitamin D, atrial fibrillation, and the
Renin-Angiotensin-Aldosterone System</article-title><source>Am J Cardiol</source><year>2018</year><volume>122</volume><issue>5</issue><fpage>780</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2018.05.013</pub-id><pub-id pub-id-type="pmid">30057228</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusaro</surname><given-names>M</given-names></name><name><surname>Gallieni</surname><given-names>M</given-names></name><name><surname>Rebora</surname><given-names>P</given-names></name><name><surname>Rizzo</surname><given-names>MA</given-names></name><name><surname>Luise</surname><given-names>MC</given-names></name><name><surname>Riva</surname><given-names>H</given-names></name><etal/></person-group><article-title>Atrial fibrillation and low vitamin D levels are associated with
severe vascular calcifications in hemodialysis patients</article-title><source>J Nephrol</source><year>2016</year><volume>29</volume><issue>3</issue><fpage>419</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1007/s40620-015-0236-7</pub-id><pub-id pub-id-type="pmid">26493621</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>JS</given-names></name><name><surname>Sachs</surname><given-names>MC</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Patton</surname><given-names>KK</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Hoofnagle</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Fibroblast growth factor-23 and incident atrial fibrillation: the
Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health
Study (CHS)</article-title><source>Circulation</source><year>2014</year><volume>130</volume><issue>4</issue><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005499</pub-id><pub-id pub-id-type="pmid">24920722</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Muto</surname><given-names>T</given-names></name><name><surname>Hino</surname><given-names>R</given-names></name><name><surname>Takeuchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>FGF-23 is a potent regulator of vitamin D metabolism and
phosphate homeostasis</article-title><source>J Bone Miner Res</source><year>2004</year><volume>19</volume><issue>3</issue><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1359/JBMR.0301264</pub-id><pub-id pub-id-type="pmid">15040831</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanafy</surname><given-names>DA</given-names></name><name><surname>Chang</surname><given-names>SL</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Kao</surname><given-names>YH</given-names></name><name><surname>Huang</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Electromechanical effects of 1,25-dihydroxyvitamin d with
antiatrial fibrillation activities</article-title><source>J Cardiovasc Electrophysiol</source><year>2014</year><volume>25</volume><issue>3</issue><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1111/jce.12309</pub-id><pub-id pub-id-type="pmid">24152033</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canpolat</surname><given-names>U</given-names></name><name><surname>Yayla</surname><given-names>&#x000c7;</given-names></name><name><surname>Akboga</surname><given-names>MK</given-names></name><name><surname>&#x000d6;zcan</surname><given-names>EH</given-names></name><name><surname>Turak</surname><given-names>O</given-names></name><name><surname>&#x000d6;zcan</surname><given-names>F</given-names></name><etal/></person-group><article-title>Effect of vitamin D replacement on atrial electromechanical delay
in subjects with vitamin D deficiency</article-title><source>J Cardiovasc Electrophysiol</source><year>2015</year><volume>26</volume><issue>6</issue><fpage>649</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1111/jce.12656</pub-id><pub-id pub-id-type="pmid">25772677</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>McCabe</surname><given-names>EL</given-names></name><name><surname>Booth</surname><given-names>SL</given-names></name><name><surname>Jacques</surname><given-names>PF</given-names></name><etal/></person-group><article-title>Vitamin D status is not related to development of atrial
fibrillation in the community</article-title><source>Am Heart J</source><year>2011</year><volume>162</volume><issue>3</issue><fpage>538</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2011.06.013</pub-id><pub-id pub-id-type="pmid">21884873</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitezova</surname><given-names>A</given-names></name><name><surname>Cartolano</surname><given-names>NS</given-names></name><name><surname>Heeringa</surname><given-names>J</given-names></name><name><surname>Zillikens</surname><given-names>MC</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><etal/></person-group><article-title>Vitamin D and the risk of atrial fibrillation--the Rotterdam
Study</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><issue>5</issue><elocation-id>e0125161</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125161</pub-id><pub-id pub-id-type="pmid">25933375</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Misialek</surname><given-names>JR</given-names></name><name><surname>Michos</surname><given-names>ED</given-names></name><name><surname>Eckfeldt</surname><given-names>J</given-names></name><name><surname>Selvin</surname><given-names>E</given-names></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><etal/></person-group><article-title>Serum 25-hydroxyvitamin D and the incidence of atrial
fibrillation: the atherosclerosis Risk in Communities (ARIC)
study</article-title><source>Europace</source><year>2016</year><volume>18</volume><issue>8</issue><fpage>1143</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1093/europace/euv395</pub-id><pub-id pub-id-type="pmid">26847078</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vacek</surname><given-names>JL</given-names></name><name><surname>Vanga</surname><given-names>SR</given-names></name><name><surname>Good</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>SM</given-names></name><name><surname>Lakkireddy</surname><given-names>D</given-names></name><name><surname>Howard</surname><given-names>PA</given-names></name></person-group><article-title>Vitamin D deficiency and supplementation and relation to
cardiovascular health</article-title><source>Am J Cardiol</source><year>2012</year><volume>109</volume><issue>3</issue><fpage>359</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2011.09.020</pub-id><pub-id pub-id-type="pmid">22071212</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerit</surname><given-names>L</given-names></name><name><surname>Kemal</surname><given-names>H</given-names></name><name><surname>Gulsen</surname><given-names>K</given-names></name><name><surname>Ozcem</surname><given-names>B</given-names></name><name><surname>Cerit</surname><given-names>Z</given-names></name><name><surname>Duygu</surname><given-names>H</given-names></name></person-group><article-title>Relationship between Vitamin D and the development of atrial
fibrillation after on-pump coronary artery bypass graft
surgery</article-title><source>Cardiovasc J Afr</source><year>2017</year><volume>28</volume><issue>2</issue><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.5830/CVJA-2016-064</pub-id><pub-id pub-id-type="pmid">27701486</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerit</surname><given-names>L</given-names></name><name><surname>&#x000d6;zcem</surname><given-names>B</given-names></name><name><surname>Cerit</surname><given-names>Z</given-names></name><name><surname>Duygu</surname><given-names>H</given-names></name></person-group><article-title>Preventive effect of preoperative vitamin D supplementation on
postoperative atrial fibrillation</article-title><source>Braz J Cardiovasc Surg</source><year>2018</year><volume>33</volume><issue>4</issue><fpage>347</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.21470/1678-9741-2018-0014</pub-id><pub-id pub-id-type="pmid">30184031</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shadvar</surname><given-names>K</given-names></name><name><surname>Ramezani</surname><given-names>F</given-names></name><name><surname>Sanaie</surname><given-names>S</given-names></name><name><surname>Maleki</surname><given-names>TE</given-names></name><name><surname>Arbat</surname><given-names>BK</given-names></name><name><surname>Nagipour</surname><given-names>B</given-names></name></person-group><article-title>Relationship between plasma level of vitamin D and post operative
atrial fibrillation in patients undergoing CABG</article-title><source>Pak J Med Sci</source><year>2016</year><volume>32</volume><issue>4</issue><fpage>900</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.12669/pjms.324.10587</pub-id><pub-id pub-id-type="pmid">27648036</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emren</surname><given-names>SV</given-names></name><name><surname>Aldemir</surname><given-names>M</given-names></name><name><surname>Ada</surname><given-names>F</given-names></name></person-group><article-title>Does deficiency of vitamin D increase new onset atrial
fibrillation after coronary artery bypass grafting surgery</article-title><source>Heart Surg Forum</source><year>2016</year><volume>19</volume><issue>4</issue><fpage>E180</fpage><lpage>E184</lpage><pub-id pub-id-type="doi">10.1532/hsf.1531</pub-id><pub-id pub-id-type="pmid">27585197</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gode</surname><given-names>S</given-names></name><name><surname>Aksu</surname><given-names>T</given-names></name><name><surname>Demirel</surname><given-names>A</given-names></name><name><surname>Sunbul</surname><given-names>M</given-names></name><name><surname>Gul</surname><given-names>M</given-names></name><name><surname>Bakir</surname><given-names>I</given-names></name><etal/></person-group><article-title>Effect of vitamin D deficiency on the development of
postoperative atrial fibrillation in coronary artery bypass
patients</article-title><source>J Cardiovasc Thorac Res</source><year>2016</year><volume>8</volume><issue>4</issue><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.15171/jcvtr.2016.29</pub-id><pub-id pub-id-type="pmid">28210468</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;zsin</surname><given-names>KK</given-names></name><name><surname>Sanri</surname><given-names>US</given-names></name><name><surname>Toktas</surname><given-names>F</given-names></name><name><surname>Kahraman</surname><given-names>N</given-names></name><name><surname>Yavuz</surname><given-names>S</given-names></name></person-group><article-title>Effect of plasma level of vitamin D on postoperative atrial
fibrillation in patients undergoing isolated coronary artery bypass
grafting</article-title><source>Braz J Cardiovasc Surg</source><year>2018</year><volume>33</volume><issue>3</issue><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.21470/1678-9741-2017-0214</pub-id><pub-id pub-id-type="pmid">30043913</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qayyum</surname><given-names>F</given-names></name><name><surname>Landex</surname><given-names>NL</given-names></name><name><surname>Agner</surname><given-names>BR</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>J&#x000f8;ns</surname><given-names>C</given-names></name><name><surname>Dixen</surname><given-names>U</given-names></name></person-group><article-title>Vitamin D deficiency is unrelated to type of atrial fibrillation
and its complications</article-title><source>Dan Med J</source><comment>[Internet]</comment><year>2012</year><date-in-citation content-type="access-date">2019 Apr 27</date-in-citation><volume>59</volume><issue>9</issue><elocation-id>A4505</elocation-id><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22951200">https://www.ncbi.nlm.nih.gov/pubmed/22951200</ext-link></comment><pub-id pub-id-type="pmid">22951200</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname><given-names>HT</given-names></name><name><surname>Bair</surname><given-names>TL</given-names></name><name><surname>Lapp&#x000e9;</surname><given-names>DL</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Horne</surname><given-names>BD</given-names></name><name><surname>Carlquist</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Association of vitamin D levels with incident depression among a
general cardiovascular population</article-title><source>Am Heart J</source><year>2010</year><volume>159</volume><issue>6</issue><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2010.03.017</pub-id><pub-id pub-id-type="pmid">20569717</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canpolat</surname><given-names>U</given-names></name><name><surname>Aytemir</surname><given-names>K</given-names></name><name><surname>Hazirolan</surname><given-names>T</given-names></name><name><surname>&#x000d6;zer</surname><given-names>N</given-names></name><name><surname>Oto</surname><given-names>A</given-names></name></person-group><article-title>Relationship between vitamin D level and left atrial fibrosis in
patients with lone paroxysmal atrial fibrillation undergoing
cryoballoon-based catheter ablation</article-title><source>J Cardiol</source><year>2017</year><volume>69</volume><issue>1</issue><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.jjcc.2016.06.012</pub-id><pub-id pub-id-type="pmid">27554047</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demir</surname><given-names>M</given-names></name><name><surname>Uyan</surname><given-names>U</given-names></name><name><surname>Melek</surname><given-names>M</given-names></name></person-group><article-title>The effects of vitamin D deficiency on atrial
fibrillation</article-title><source>Clin Appl Thromb Hemost</source><year>2014</year><volume>20</volume><issue>1</issue><fpage>98</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1177/1076029612453762</pub-id><pub-id pub-id-type="pmid">22826443</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>WR</given-names></name><name><surname>Liu</surname><given-names>ZY</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>DW</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Sha</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Relation of low vitamin D to nonvalvular persistent atrial
fibrillation in Chinese patients</article-title><source>Ann Noninvasive Electrocardiol</source><year>2014</year><volume>19</volume><issue>2</issue><fpage>166</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1111/anec.12105</pub-id><pub-id pub-id-type="pmid">24206389</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozcan</surname><given-names>OU</given-names></name><name><surname>Gurlek</surname><given-names>A</given-names></name><name><surname>Gursoy</surname><given-names>E</given-names></name><name><surname>Gerede</surname><given-names>DM</given-names></name><name><surname>Erol</surname><given-names>C</given-names></name></person-group><article-title>Relation of vitamin D deficiency and new-onset atrial
fibrillation among hypertensive patients</article-title><source>J Am Soc Hypertens</source><year>2015</year><volume>9</volume><issue>4</issue><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.jash.2015.01.009</pub-id><pub-id pub-id-type="pmid">25753298</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belen</surname><given-names>E</given-names></name><name><surname>Aykan</surname><given-names>AC</given-names></name><name><surname>Kalaycioglu</surname><given-names>E</given-names></name><name><surname>Sungur</surname><given-names>MA</given-names></name><name><surname>Sungur</surname><given-names>A</given-names></name><name><surname>Cetin</surname><given-names>M</given-names></name></person-group><article-title>Low-level vitamin D is associated with atrial fibrillation in
patients with chronic heart failure</article-title><source>Adv Clin Exp Med</source><year>2016</year><volume>25</volume><issue>1</issue><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.17219/acem/34690</pub-id><pub-id pub-id-type="pmid">26935498</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>CY</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><etal/></person-group><article-title>Meta-analysis of vitamin D deficiency and risk of atrial
fibrillation</article-title><source>Clin Cardiol</source><year>2016</year><volume>39</volume><issue>9</issue><fpage>537</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1002/clc.22563</pub-id><pub-id pub-id-type="pmid">27556176</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WL</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>HB</given-names></name><name><surname>Yang</surname><given-names>CJ</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><article-title>Vitamin D and new-onset atrial fibrillation: A meta-analysis of
randomized controlled trials</article-title><source>Hellenic J Cardiol</source><year>2018</year><volume>59</volume><issue>2</issue><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.hjc.2017.11.006</pub-id><pub-id pub-id-type="pmid">29154815</pub-id></element-citation></ref></ref-list></back></article>